Cited by 16Bipolar Disorder and TreatmentTreatment of Major DepressionCircadian rhythm and melatonin

Bright Light Therapy in the Morning or at Mid-Day in the Treatment of Non-Seasonal Bipolar Depressive Episodes (LuBi): Study Protocol for a Dose Research Phase I / II Trial

Open access
Geoffroy, Pierre Alexis, Abbassi, El Mountacer Billah El, Maruani, Julia, Etain, Bruno, Lejoyeux, Michel, Amad, Ali, Courtet, Philippe, Dubertret, Caroline +4 more·2018·Psychiatry Investigation

Abstract

Objective This study protocol aims to determine, using a rigorous approach in patients with bipolar disorder (BD) and non-seasonal major depressive episode (MDE), the characteristics of bright light therapy (BLT) administration (duration, escalation, morning and mid-day exposures) depending on the tolerance (hypomanic symptoms). Methods Patients with BD I or II and treated by a mood stabilizer are eligible. After 1 week of placebo, patients are randomized between either morning or mid-day exposure for 10 weeks of active BLT with glasses using a dose escalation at 7.5, 10, 15, 30 and 45 minutes/day. A further follow-up visit is planned 6 months after inclusion. Patients will be included by cohorts of 3, with at least 3 days of delay between them, and 1 week between cohorts. If none meet a dose limiting toxicity (DLT; i.e hypomanic symptoms), the initiation dose of the next cohort will be increased. If one patient meet a DLT, an additionnal cohort will start at the same dose. If 2 or 3 patients meet a DLT, from the same cohort or from two cohorts at the same dose initiation, the maximum tolerated dose is defined. This dose escalation will also take into account DLTs observed during the intra-subject escalation on previous cohorts, with a "Target Ceiling Dose" defined if 2 DLTs occured at a dose. Discussion Using an innovative and more ergonomic device in the form of glasses, this study aims to better codify the use of BLT in BD to ensure a good initiation and tolerance. Trial registrationaaClinicalTrials.gov Identifier: NCT03396744.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.30773/pi.2018.09.27.1

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 56 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. [14]Geoffroy PA Fovet T Micoulaud-Franchi JA Boudebesse C Thomas P Etain B Bright light therapy in seasonal bipolar depressions L’Encéphale 2015 41 527 533 26481654
  2. [33]First MB Structured Clinical Interview for the DSM (SCID). The Encyclopedia of Clinical Psychology [Internet] John Wiley & Sons, Inc 2014 Available at: http://onlinelibrary.wiley.com/doi/10.1002/9781118625392.wbecp351/abstract. Accessed November 27, 2017 · DOI

Cited by

Sorted by citations

Authors
Geoffroy, P. A., Abbassi, E. M. B. E., Maruani, J., Etain, B., Lejoyeux, M., Amad, A., Courtet, P., Dubertret, C., Gorwood, P., Vaiva, G., Bellivier, F., & Chevret, S.
Affiliations
  • Inserm (FR)
  • Assistance Publique – Hôpitaux de Paris (FR)
  • Centre National de la Recherche Scientifique (FR)
Corresponding author
Geoffroy, Pierre Alexis
Venue
Psychiatry Investigation
Published
2018-12-25
Volume
15
Issue
12
Pages
1188-1202
ISSN
  • 1738-3684 (ISSN-L)
  • 1976-3026
OpenAlex
W2900814542
Cited by
16
References
56
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2021: 1 · 2020: 3 · 2019: 6 · 2018: 1
FWCI
2.16
Type
journal article
Language
en
Open access
Locations
  • Psychiatry Investigation (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Funders
Assistance Publique Hôpitaux de Paris
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
Keywords
bright light therapy, bipolar disorder, dose escalation, maximum tolerated dose, dose-limiting toxicity, hypomanic symptoms, mood stabilizers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review